Acumulado Enero - Diciembre 2023 (93 - 96) N°93
ISSN 1317-987X
 
Buscar




Artículos
 
Introduction
Methods
Results
Discussion
References




Bioquímica cerebral
1H Magnetic Resonance Spectroscopy (MRS) assessment of the effects of Eicosapentaenoic-Docosahexaenoic Acids and Choline-Inositol supplementation on Children with Attention Deficit Hyperactivity Disorder (ADHD)

References

  1. Hoffmann H.: Der Struwwelpeter oder lustige Geschichten und drollige Bilder für Kinder von 3 bis 6 Jahren. 588. Auflage; Originalausgabe von Verlag Rütten & Löning, Frankfurt am Main. Bei Loewes Verlag Ferdinand Carl, Stuttgart 1934
  2. Still G. Some abnormal psychical conditions in children. Lancet. 1902;1:1008-1012, 1077-1082, 1163-1168.
  3. Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM-IV-TR). Diagnosis, Etiology and Treatment 2004; Michael B. First (Editor), Allan Tasman (Editor) Wiley, John & Sons Washington DC. American Psychiatric Association; 4th edition, June 2000
  4. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Cantwell DP: Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998; 351:429?433
  5. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Lange NL, Kaysen D, Krain AL, Ritchie GF, Rajapakse JC, Rapoport JL: Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53:607?616
  6. Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J: Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder and normal controls. Neurology 1996; 48:589?601
  7. Casey BJ, Trainor R, Giedd J, Vauss Y, Vaituzis CK, Hamburger S, Kozuch P, Rapoport JL: The role of the anterior cingulote in automatic and controlled processes, a developmental neuroanatomical study. Dev Psychobiol 1997; 30:61?69
  8. Aylward EH, Reiss AL, Reader MJ, Singer HS, Brown JE, Denckla MB: Basal ganglia volumes in children with attention deficit-hyperactivity disorder. J Child Neurol 1996; 11:112?115
  9. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D: Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity. Arch Neurol 1990; 47:919?922
  10. Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T, Vaituzis AC, Blumenthal JD, Nelson J, Bastain TM, Zijdenbos A, Evans AC, Rapoport JL. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001;58(3):289-95.
  11. Castellanos F., Acosta M. Neuroanatomía del trastorno por déficit de atención con hiperactividad Rev. Neurol. 2004; 38 (Supl 1): S131-136
  12. Durston S, Hulshoff Pol HE, Schnack HG, Buitelaar JK, Steenhuis MP, Minderaa RB, Kahn RS, van Engeland H. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry. 2004;43(3):332-40.
  13. Alvarado A y Hernández N.: Fundamentos Bioquímicos y Aplicaciones de la Espectroscopía de Hidrógeno por Resonancia Magnética. Rev. Fac. Med. 2000; 23 (Supl 1): 18-20,
  14. Alvarado A., Díaz, L., Itriago S., Sucre,Z., Mayobre,F. and Itriago P.:1H Magnetic Resonance Spectroscopy (MRS) in Attention Déficit Hyperactivity Disorder (ADHD). Radiology 1999; 213: 464.
  15. Alvarado A, Zapata G, Díaz L, Sucre Z, Veracoechea G, Pérez R, Hernández M and Itriago F.: Proton Magnetic Resonance Spectroscopy and Electroencephalograpic Activity in Attention Déficit Disorder. Vitae 2003;(15). http:// caibco.ucv.ve / vitae / vitaequince / artículos / bioquímicacerebral / archivos
  16. Z. Jin, Y.F. Zang, Y.W. Zeng, L. Zhang, Y.F. Wang: Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: A 1H-Magnetic Resonance Spectroscopy study. Neuroscience Letters 2001; 315: 45?48
  17. Carrey N, MacMaster FP, Sparkes SJ, Khan SC, Kusumakar V. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. J Child Adolesc Psychopharmacol 2002;12(4):331-6
  18. Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S, Schmidt M. Metabolite changes resulting from treatment in children with ADHD: A 1H-MRS study. Clin Neuropharmacol. 2003; 26(4): 218-21.
  19. MacMaster FP, Carrey N, Sparkes S, Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry. 2003; 53(2):184-7.
  20. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci. 2004; 16(1):63-9.
  21. Yeo RA, Hill DE, Campbell RA, Vigil J, Petropoulos H, Hart B, Zamora L, Brooks WM.: Proton magnetic resonance spectroscopy investigation of the right frontal lobe in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry.2003;42(3):303-10
  22. Chandan J. Vaidya , Austin G, Kirkorian G, Ridlehuber H, Desmond J,. Glover G and Gabrieli J. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. PNAS 1998; 95( 24): 14494-14499
  23. Rubia K, Overmeyer S, Taylor E, Brammer M, Williams S, Simmons A, and Bullmore E. Hypofrontality in Attention Deficit Hyperactivity Disorder During Higher-Order Motor Control: A Study With Functional MRI. Am J Psychiatry 1999; 156:891?896
  24. Anderson CM, Polcari A, Lowen SB, Renshaw PF, Teicher MH. Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD. Am J Psychiatry. 2002 ;159(8):1322-8.
  25. Zametkin A, Nordahl T, Gross M, King A, Semple W, Rumsey J, Hamburger S , Cohen R.: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N. Eng. J Med. 1990; 323(15):1361-1366
  26. Amen, DG, Paldi, JH, Thisted, R: Evaluating ADHD with Brain SPECT Imaging. J Child Adol Psychiatry 1993;32:1080-1081,
  27. Amen DG.: Healing ADD: The Breakthrough Program That Allows You to See and Heal the 6 Types of ADD. 2002, Berkley Publishing Group.
  28. Stevens, L.J., Zentall, S.S., Deck, J.L. Abate, M.L., Watkins, B.A., Lipp, S.R., & Burgess. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition 1995; 62: 761-768.
  29. Burgess J, Stevens L, Zhang W, Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr 2000;71:327-330
  30. Levine, B S. Most frequently asked questions about DHA. Nutrition Today 1997; 32: 248-249 .
  31. Stevens LJ, Zentall SS, Deck JL, Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995;62:761-768.
  32. Stevens LJ, Zentall SS, Abate ML, et al. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav 1996;59:915-920.
  33. Mitchell EA, Aman MG, Turbott SH, et al. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr 1987;26:406-411.
  34. Makrides M, Neumann M, Simmer K, et al. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995;345:1463-1467.
  35. Colquhoun I, Bunday S. A lack of essential fatty acids as a possible cause of hyperactivity in children. Med Hypotheses 1981;7:673-679.
  36. Stordy BJ Dyslexia, attention deficit hyperactivity disorder, dyspraxia - do fatty acids help? Dyslexia Review 1997; 9(2).
  37. Bekaroglu M, Aslan Y, Gedik Y. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J Child Psychol Psychiatry. 1996;37(2):225-7
  38. Bekaroglu M, Aslan Y, Gedik Y, et al. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J Child Psychol Psychiatry 1996;37:225-227.
  39. Gibson RA. The effect of dietary supplementation with evening primrose oil on hyperkinetic children. Proc Nutr Soc Aust 1985; 10:196-199.
  40. Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J Abnorm Child Psychol. 1987;15(1):75-90
  41. Richardson, A.J., Puri, B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002; 26(2): 233-9.
  42. Kalmijn, S., et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997; 42(5): 776-82
  43. Hamazaki T, Sawazaki S, Itomural M, Asaoka E, Nagao Y, Nishimura N, Yazawa K, Kuwamori T, Kobayashi M. The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest 1975;97(4):1129-33.
  44. Mitchell EA, Lewis S, Cutler DR. Essential fatty acids and maladjusted behavior in children. Prostaglandins Leukot Med 1983;12(3):281-7.
  45. Richardson, A.J., Puri, B.K. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fatty Acids 2000;63(1-2): 79-87.
  46. Richardson, A.J., Puri, B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002; 26(2): 233-9.
  47. Richardson, A.J., Ross, M.A. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 2000; 63(1-2): 1-9.
  48. Jorisse, B.L., Brouns, F., Van Boxtel, M.P., Ponds, R.W., Verhey, F.R., Jolles, J., Riedel, W.J. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr. Neurosci. 2001; 4(2): 121-34.
  49. Yeo RA, Hill D, Campbell R, Vigil J, Brooks WM. Developmental instability and working memory ability in children: a magnetic resonance spectroscopy investigation. Dev Neuropsychol. 2000;17(2):143-59.
  50. Jimenez JV, Richards TL, Heide AC, Grierson JR, Shankland EG. Incorporation of a phosphonium analogue of choline into the rat brain as measured by magnetic resonance spectroscopy. Magn Reson Med. 1995;33(3):285-92.
  51. Millington WR, Wurtman RJ. Choline administration elevates brain phosphorylcholine concentrations. J Neurochem. 1982;38(6):1748-52.
  52. Stoll AL, Renshaw PF, De Micheli E, Wurtman R, Pillay SS, Cohen BM. Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry. 1995;37(3):170-174.
  53. Babb SM, Wald LL, Cohen BM, Villafuerte RA, Gruber SA, Yurgelun-Todd DA, Renshaw PF. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology 2002 ;161(3):248-54
  54. Babb SM, Ke Y, Lange N, Kaufman MJ, Renshaw. Oral choline increases choline metabolites in human brain. Psychiatry Res. 2004;130(1):1-9.
  55. Babb SM, Appelmans KE, Renshaw PF, Wurtman RJ, Cohen BM. Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy. Psychopharmacology 1996;127(2):88-94.
  56. Tan J, Bluml S, Hoang T, Dubowitz D, Mevenkamp G, Ross B. Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain. Magn Reson Med. 1998;39(6):1005-10.
  57. Miller BL, Chang L, Booth R, Ernst T, Cornford M, Nikas D, McBride D, Jenden DJ. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci. 1996;58(22):1929-35.
  58. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM. Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA. 1995;274(11):902-7.
  59. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, Inubushi T. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci. 1996;21(4):248-54.
  60. Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J Abnorm Child Psychol 1987; 15: 75-90.
  61. Arnold LE, Kleykamp D, Votolato NA, Taylor WA, Kontras SB, Tobin K. Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine. Biol Psychiatry 1989; 25: 222-228.
  62. Arnold LE, Kleykamp D, Votolato NA, Gibson RA, Horrocks L. Potential link between dietary intake of fatty acids and behavior: pilot exploration of serum lipids in ADHD. J Child Adolesc Psychopharmacol 1994; 4: 171-180.
  63. Bourre J-M, Bonneil M, Clement M, et al. Function of dietary polyunsaturated fatty acids in the nervous system. Prostaglandins Leukotr Essent Fatty Acids 1993; 48: 5-15.
  64. Bourre J-M, Durand G, Pascal G, Youyou A. Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat. J Nutr 1988; 119: 15-22.
  65. Burgess JR. Attention deficit hyperactivity disorder: observational and interventional studies. NIH workshop on omega-3 essential fatty acids and psychiatric disorders. National Institutes of Health: Bethesda, 1998, Sept. 2-3.
  66. Burgess JR, Stevens L, Zhang W, Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr 2000; 71: 327-330.
  67. Stoll AL, Sachs GS, Cohen BM. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry 1996; 40(5):382-388.
  68. Benjamin J, Agam G, Levine J, et al. Inositol treatment in psychiatry. Psychopharmacol Bull 1995;31(1): 167?175.
  69. Benjamin J, Levine J, Fux M, et al. Double-blind, placebo-controlled, crossover trial of Inositol treatment for panic disorder. Am J Psychiatry 1995;152: 1084?1086.
  70. Levine J, Barak Y, Kofman O, and Belmaker RH. Follow-up and relapse analysis of an Inositol study of depression. Isr J Psychiatry Relat Sci 1995;32(1): 14?21.
  71. Levine J. Controlled trials of Inositol in psychiatry. Eur Neuropsychopharmacol 1997;7:147?155.
  72. Einat H, Belmaker RH. The effects of Inositol treatment in animal models of psychiatric disorders J Affect Disord. 2001; 62(1-2):113-21.
Introduction
Methods
Results
Discussion
References

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit